1. Berk PD, Wasserman LR, Fruchtman SM, Goldberg JD . Treatment of polycythemia vera: a summary of clinical trials conducted by the Polycythemia Vera Study Group. In: Wasserman LR, Berk PD, Berlin NI (eds). Polycythemia Vera and the Myeloproliferative Disorders. W.B. Saunders: Philadelphia, 1995; pp 166–194.
2. McMullin MF, Reilly JT, Campbell P, Bareford D, Green AR, Harrison CN et al. Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis. Br J Haematol 2007; 138: 821–822.
3. Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092–1097.
4. Thiele J, Kvasnicka HM, Orazi A, Tefferi A, Birgegard G . Polycythaemia vera. In: Swerdlow S, Campo E, Harris N, et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008; pp 40–43.
5. Campbell PJ, Green AR . The myeloproliferative disorders. N Engl J Med 2006; 355: 2452–2466.